The optimal indication of phototherapy in a neonatal jaundice is:

BHU NO-2019

Child Health Nursing (Pediatrics)

Easy

Appeared in: BHU NO-2019

Explanation

A total serum bilirubin (TSB) level of 15 mg/dL is a widely accepted threshold for initiating phototherapy in healthy term infants, particularly between 25 and 48 hours of age.
This level is chosen as a balance to effectively reduce bilirubin and prevent it from rising to neurotoxic levels, which could lead to kernicterus (brain damage).
According to Kramer's rule, jaundice extending to the arms and lower legs (Zone 4) corresponds to a bilirubin level of approximately 15–18 mg/dL, signaling the need for intervention.
The American Academy of Pediatrics (AAP) guidelines, while based on age in hours and risk factors, support initiating phototherapy around this level for low-risk term infants.

Option A: A bilirubin level of 10 mg/dL is often within the range of physiological jaundice for a term newborn after 24 hours and typically does not require intervention unless the infant is preterm or has specific risk factors.
Option B: A bilirubin level of 20 mg/dL indicates severe hyperbilirubinemia. At this point, phototherapy alone may be insufficient, and more aggressive treatment, such as an exchange transfusion, is strongly considered to rapidly lower bilirubin levels.
Option D: A bilirubin level of 5 mg/dL is the approximate threshold at which jaundice becomes clinically visible (usually on the face). This is a common finding in the first few days of life and is considered physiological, not requiring treatment.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Management of Neonatal Hyperbilirubinemia as background academic context rather than a clinical decision trigger.
The primary goal of managing neonatal jaundice is to prevent kernicterus, a rare but devastating form of brain damage caused by excessive bilirubin levels. Timely initiation of phototherapy is a key nursing responsibility.
Nurses play a vital role in assessing for jaundice (using methods like Kramer's rule), monitoring bilirubin levels, and implementing phototherapy correctly and safely.
What if? If the infant was born preterm at 32 weeks, the threshold for phototherapy would be much lower. For example, treatment might be started at a bilirubin level of 8-12 mg/dL, as preterm infants are more vulnerable to bilirubin neurotoxicity at lower levels.

How to Approach the Question

First, identify the core of the question, which asks for the 'optimal indication' (i.e., the standard treatment threshold) for phototherapy in neonatal jaundice.
Recall the different levels of hyperbilirubinemia and their significance. Mentally categorize them: visible jaundice, physiological jaundice, phototherapy level, and exchange transfusion level.
Evaluate the options against this mental framework.
Eliminate 5 mg/dL, as this is the level of visibility, not treatment.
Eliminate 20 mg/dL, as this is a critical level that often requires a more aggressive intervention like exchange transfusion.
Between 10 mg/dL and 15 mg/dL, recognize that 15 mg/dL is the more standard and widely cited threshold for initiating phototherapy in an otherwise healthy, term newborn.

Concept Tested & Keywords

Concept Tested: Management of Neonatal Hyperbilirubinemia
Stem keywords: neonatal jaundice, phototherapy, optimal indication, bilirubin level
Lead-in keywords: optimal indication

QpKBSsrniEzxzfenIOS_8e

E6 Text Book Of Pediatric Nursing 3rd Panchali Pal — Part 1 (pp 36-238 of 713) p. 193-195

E6 Nelson Textbook of Pediatrics(2024) — Volume 1 p. 1124-1126